Jeroen B. Van Beek - Sep 29, 2021 Form 4 Insider Report for Allovir, Inc. (ALVR)

Role
Chief Commercial Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Sep 29, 2021
Transactions value $
-$416,906
Form type
4
Date filed
10/1/2021, 05:58 PM
Previous filing
Sep 20, 2021
Next filing
Nov 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$25K -1K -0.23% $25.04* 434K Sep 29, 2021 Direct F1, F2
transaction ALVR Common Stock Sale -$306K -12.2K -2.8% $25.17* 422K Sep 30, 2021 Direct F1, F3
transaction ALVR Common Stock Sale -$85.6K -3.41K -0.81% $25.07* 419K Oct 1, 2021 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2020.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.10. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.46. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.